A diagnostically difficult case of a cellular pleural fluid: Morphology, immunohistochemistry, and fluorescence in situ hybridization study.

about

A diagnostically difficult case of a cellular pleural fluid: Morphology, immunohistochemistry, and fluorescence in situ hybridization study.

Item

http://www.wikidata.org/entity/Q41272473

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A diagnostically difficult cas ...... e in situ hybridization study.

@en

type

Item

label

A diagnostically difficult cas ...... e in situ hybridization study.

@en

prefLabel

A diagnostically difficult cas ...... e in situ hybridization study.

@en

P1476

A diagnostically difficult cas ...... e in situ hybridization study.

@en

P2093

Amarpreet Bhalla

http://www.w3.org/2001/XMLSchema#string

Minhua Wang

http://www.w3.org/2001/XMLSchema#string

N Paul Ohori

http://www.w3.org/2001/XMLSchema#string

Nora K Frisch

http://www.w3.org/2001/XMLSchema#string

Shabnam Samankan

http://www.w3.org/2001/XMLSchema#string

P2860

Germline BAP1 mutations predispose to malignant mesothelioma

Guidelines for the diagnosis and treatment of malignant pleural mesothelioma

The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.

Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

The established and future biomarkers of malignant pleural mesothelioma.

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.

Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.

Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/CYTOJOURNAL.CYTOJOURNAL_54_16

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28828031

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

5545827

http://www.w3.org/2001/XMLSchema#string